A phase I study of oral uracil/ftorafur (UFT) plus leucovorin and bis-acetato-ammine-dichloro-cyclohexylamine-platinum IV (JM-216) each given over 14 days every 28 days. [electronic resource]
Producer: 19990413Description: 385-8 p. digitalISSN:- 0344-5704
- Administration, Oral
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Drug Administration Schedule
- Drug Combinations
- Humans
- Leucovorin -- administration & dosage
- Neoplasms -- drug therapy
- Organoplatinum Compounds -- administration & dosage
- Tegafur -- administration & dosage
- Treatment Outcome
- Uracil -- administration & dosage
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.